HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Habryka Selected Research

WP760

10/2017Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Habryka Research Topics

Disease

3Neoplasms (Cancer)
10/2017 - 10/2011
3Hypoxia (Hypoxemia)
09/2015 - 10/2011
2Melanoma (Melanoma, Malignant)
10/2017 - 10/2011
1Neoplasm Metastasis (Metastasis)
06/2014

Drug/Important Bio-Agent (IBA)

1WP760IBA
10/2017
1Daunorubicin (Cerubidine)FDA LinkGeneric
10/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017
1AnthracyclinesIBA
10/2017
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2015
1Staphylococcal Protein A (Protein A)IBA
06/2014
1Interleukin-8 (Interleukin 8)IBA
01/2014
1Epidermal Growth Factor (EGF)IBA
01/2014
1Proteins (Proteins, Gene)FDA Link
10/2011
1Fibronectins (Fibronectin)IBA
10/2011
1NM23 Nucleoside Diphosphate KinasesIBA
10/2011
1Galectin 3 (LGALS3)IBA
10/2011
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2011
1Microphthalmia-Associated Transcription FactorIBA
10/2011
1CD146 AntigenIBA
10/2011
1Oxygen (Dioxygen)IBA
10/2011

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2017